Annovis Bio, Inc. (ANVS)
1.31
-0.02
(-1.50%)
USD |
NYSE |
Sep 25, 16:00
1.31
0.00 (0.00%)
Pre-Market: 19:59
Annovis Bio Price : 1.31 for Sept. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | 1.35 | 1.36 | 1.305 | 1.31 | 573617.0 |
| Sep 24, 2026 | 1.27 | 1.34 | 1.23 | 1.33 | 855174.0 |
| Sep 23, 2026 | 1.30 | 1.33 | 1.235 | 1.27 | 1.146M |
| Sep 22, 2026 | 1.19 | 1.30 | 1.185 | 1.26 | 1.215M |
| Sep 21, 2026 | 1.16 | 1.22 | 1.16 | 1.19 | 885902.0 |
| Sep 18, 2026 | 1.12 | 1.16 | 1.09 | 1.14 | 681977.0 |
| Sep 17, 2026 | 1.10 | 1.17 | 1.08 | 1.10 | 1.523M |
| Sep 16, 2026 | 1.12 | 1.13 | 1.04 | 1.04 | 1.433M |
| Sep 15, 2026 | 1.14 | 1.14 | 1.10 | 1.12 | 824332.0 |
| Sep 14, 2026 | 1.10 | 1.17 | 1.095 | 1.14 | 1.202M |
| Sep 11, 2026 | 1.20 | 1.231 | 1.10 | 1.12 | 1.894M |
| Sep 10, 2026 | 1.21 | 1.26 | 1.17 | 1.19 | 1.338M |
| Sep 09, 2026 | 1.31 | 1.32 | 1.22 | 1.22 | 1.748M |
| Sep 08, 2026 | 1.39 | 1.398 | 1.30 | 1.30 | 1.963M |
| Sep 04, 2026 | 1.40 | 1.44 | 1.375 | 1.39 | 1.533M |
| Sep 03, 2026 | 1.65 | 1.685 | 1.32 | 1.38 | 7.332M |
| Sep 02, 2026 | 1.71 | 1.759 | 1.69 | 1.70 | 606825.0 |
| Sep 01, 2026 | 1.73 | 1.73 | 1.67 | 1.69 | 457632.0 |
| Aug 31, 2026 | 1.72 | 1.784 | 1.70 | 1.72 | 425505.0 |
| Aug 28, 2026 | 1.78 | 1.83 | 1.71 | 1.72 | 504513.0 |
| Aug 27, 2026 | 1.76 | 1.81 | 1.76 | 1.81 | 301973.0 |
| Aug 26, 2026 | 1.84 | 1.856 | 1.76 | 1.78 | 235713.0 |
| Aug 25, 2026 | 1.76 | 1.825 | 1.76 | 1.82 | 560283.0 |
| Aug 24, 2026 | 1.83 | 1.83 | 1.74 | 1.75 | 670723.0 |
| Aug 21, 2026 | 1.78 | 1.840 | 1.77 | 1.82 | 618557.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.68 |
| Alnylam Pharmaceuticals, Inc. | 255.96 |
| Anika Therapeutics, Inc. | 20.37 |
| Savara, Inc. | 5.00 |
| Vericel Corp. | 39.71 |
Price Related Metrics
| Earnings Yield | -136.8% |
| Market Cap | 55.81M |